FDA approves Boehringer’s asthma treatment

By Danielle Brody

No Comment

Asthma-sufferers and Boehringer Ingelheim Pharmaceuticals Inc. can breathe easier – the Ridgefield-based company announced today its asthma treatment has received U.S. Food and Drug Administration approval.

This content is for Westfair Online members only. Please login to view this content. Become a member by Registering Here. If you would prefer to start with a 12 week free trial, Click Here.


About the author

Danielle Brody
Danielle is the events manager for Westfair Communications. Previously, she was a reporter for the Fairfield and Westchester County Business Journals. She has written for the Journal News, the Scarsdale Inquirer and the Newark Post. Danielle is a graduate of the University of Delaware.

Related Articles